10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2010 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2010 10-K (Filed: Feb 17, 2011) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | |
| Operating activities | |||
| Net income | $ 2,887,100 | 4,745,900 | 2,490,700 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized gains/losses on investments | (194,100) | (56,400) | (28,700) |
| Other-than-temporary impairment losses recognized in income | 39,400 | 450,200 | 1,207,900 |
| Gain/loss on disposal of assets | 1,900 | 16,400 | 7,200 |
| Gain on sale of business | (3,792,300) | ||
| Deferred income taxes | 101,800 | 61,300 | (481,400) |
| Amortization, net of accretion | 497,700 | 446,400 | 466,300 |
| Depreciation expense | 103,100 | 107,100 | 105,400 |
| Impairment of goodwill and other intangible assets | 21,100 | 262,500 | 141,400 |
| Impairment of property and equipment | 95,300 | ||
| Share-based compensation | 136,000 | 153,600 | 156,000 |
| Excess tax benefits from share-based compensation | (28,100) | (9,600) | (16,000) |
| Changes in operating assets and liabilities, net of effect of business combinations and divestitures: | |||
| Receivables, net | 109,700 | (484,200) | (558,700) |
| Other invested assets, current | 5,100 | (62,500) | 103,300 |
| Other assets | (320,100) | (119,300) | (340,200) |
| Policy liabilities | (330,700) | (748,200) | 194,900 |
| Unearned income | (158,600) | (27,300) | (26,700) |
| Accounts payable and accrued expenses | (58,200) | 952,800 | (106,300) |
| Other liabilities | (208,400) | (248,800) | (797,000) |
| Income taxes | (1,239,800) | 1,391,400 | (47,300) |
| Other, net | (43,500) | (100) | 64,600 |
| Net cash provided by operating activities | 1,416,700 | 3,038,900 | 2,535,400 |
| Investing activities | |||
| Purchases of fixed maturity securities | (10,567,200) | (7,186,800) | (5,691,200) |
| Proceeds from fixed maturity securities: | |||
| Sales | 7,215,100 | 4,096,600 | 5,194,900 |
| Maturities, calls and redemptions | 3,321,700 | 1,551,700 | 1,669,600 |
| Purchases of equity securities | (350,900) | (318,900) | (1,327,500) |
| Proceeds from sales of equity securities | 197,900 | 577,300 | 1,083,100 |
| Purchases of other invested assets | (91,400) | (49,000) | (145,000) |
| Proceeds from sales of other invested assets | 34,500 | 3,500 | 32,800 |
| Changes in securities lending collateral | (504,800) | 132,400 | 325,100 |
| Purchases of subsidiaries, net of cash acquired | (300) | (66,300) | (197,700) |
| Proceeds from sales of subsidiaries, net of cash sold | 4,672,300 | 5,000 | |
| Purchases of property and equipment | (451,400) | (378,400) | (345,600) |
| Proceeds from sale of property and equipment | 800 | 400 | 12,700 |
| Other, net | (75,500) | (32,000) | |
| Net cash (used in) provided by investing activities | (1,271,500) | 3,002,800 | 616,200 |
| Financing activities | |||
| Net repayments of commercial paper borrowings | (164,400) | (397,000) | (900,600) |
| Proceeds from long-term borrowings | 1,088,500 | 990,300 | 525,000 |
| Net proceeds from (repayments of) short-term borrowings | 100,000 | (98,000) | 98,000 |
| Repayment of long-term borrowings | (481,700) | (919,300) | (38,700) |
| Changes in securities lending payable | 504,900 | (132,400) | (325,100) |
| Changes in bank overdrafts | (28,000) | (344,100) | 44,800 |
| Repurchase and retirement of common stock | (4,360,300) | (2,638,400) | (3,276,200) |
| Proceeds from exercise of employee stock options and employee stock purchase plan | 143,600 | 126,500 | 121,200 |
| Excess tax benefits from share-based compensation | 28,100 | 9,600 | 16,000 |
| Net cash used in financing activities | (3,169,300) | (3,402,800) | (3,735,600) |
| Effect of foreign exchange rates on cash and cash equivalents | (3,200) | (6,700) | |
| Change in cash and cash equivalents | (3,027,300) | 2,632,200 | (584,000) |
| Cash and cash equivalents at beginning of year | 4,816,100 | 2,183,900 | |
| Cash and cash equivalents at end of year | 1,788,800 | 4,816,100 | 2,183,900 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |